Booz Allen Hamilton heads into its May 22 earnings print having recovered nearly 2% on the week — with shorts continuing to unwind and options traders turning notably less defensive than they were just days ago.
The positioning story has shifted since last week's note. Short interest has fallen to 6.2% of free float, down roughly 2.7% week-on-week and about 7.4% from a month ago. That unwind, which began in mid-April when shorts were closer to 8.2% of float, is still running. Borrow conditions reinforce the picture: cost to borrow is a negligible 0.39%, and availability is extraordinarily loose at over 9,000% — meaning there are nearly 100 times as many shares available to lend as there are shares currently borrowed. That is not a setup where short sellers face any squeeze pressure. The ORTEX short score has eased to 42.3, down from above 43 earlier in the month, consistent with positioning becoming less stressed.
Options have moved in the same direction — but the shift is striking. The put/call ratio has dropped to 1.43, now running more than two standard deviations below its 20-day average of 1.54. That is the least defensive options posture of the past month. After weeks of put-heavy positioning, traders appear to be reducing downside hedges ahead of Thursday's print — a meaningful rotation in tone even if the PCR remains above 1 in absolute terms.
The Street remains cautious in aggregate, though the stock has moved. BAH closed at $77, up from $75.43 when the previous note was filed — narrowing the gap to the mean analyst target of $97.23 but still leaving implied upside of around 26%. The direction of analyst targets has been consistently lower: Truist trimmed from $98 to $85 in late April, Citigroup cut from $109 to $87 in early April, and Wells Fargo initiated at Equal-Weight with an $85 target on April 1. Goldman Sachs holds its Sell rating with an $80 target — still above the current price but now closer. The EV/EBITDA multiple has drifted up modestly over the past week to around 9.9x, while the PE of roughly 11.8x reflects a business that the market is still not willing to re-rate higher without evidence. The EPS surprise factor score is a strong 85th percentile, and 90-day EPS momentum ranks at the 73rd — which gives the bulls something to work with if the print confirms the trend.
Institutional ownership is deep and stable. Vanguard, T. Rowe Price, and BlackRock collectively hold over 32% of shares. T. Rowe added nearly 900,000 shares through March — the most notable incremental move among the top holders. Insider activity through March 31 was one-directional: the CEO, COO, CFO, and general counsel all filed sales on the same date at $78.03, a cluster of routine-looking trades at a price just above where the stock trades now. The most recent buy on record is CEO Horacio Rozanski's $2 million purchase in October 2025 at $84.66 — a level the stock has not reclaimed.
Among peers, the week has been mixed. ICFI led with a 3.4% weekly gain and CBZ added 4.2%, while LDOS and CACI both dipped around 1-2%. SAIC, the closest government-IT peer, was broadly flat on the week at +1.4%. BAH's 2% gain puts it in the middle of that pack — not a standout, but holding its ground ahead of results.
Thursday's earnings call will test whether the EPS beat pattern holds against a budget backdrop that has kept analyst targets under pressure all spring.
See the live data behind this article on ORTEX.
Open BAH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
